# Blue Bear Ventures

> Blue Bear Ventures is a VC fund backing Health Care and Biotechnology. See 4 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: San Francisco, United States
- Total investments: 4
- Last investment: Sep 2019
- Lead investor: 25%
- Last fund: Dec 2021
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/blue-bear-ventures
- X (Twitter): https://twitter.com/bluebearvc
- Website: https://bbv.io

Blue Bear Ventures is a VC fund in San Francisco focused on Health Care and Biotechnology. Blue Bear Ventures (BBV) engages founders working on the frontiers of science and technology with the potential to solve some of the most pressing challenges we face in the world today.

## Contacts

5 contacts available for Blue Bear Ventures. Shizune tracks 3 team members at Blue Bear Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/blue-bear-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 75% |
| Biotechnology | 3 | 75% |
| Medical | 1 | 25% |
| Genetics | 1 | 25% |
| Software | 1 | 25% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 75% |
| Convertible Note | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Patrick Scaglia | Managing General Partner and Co-Founder | 0 | https://shizune.co/investors/profile/patrick-scaglia |
| Alic Chen | Co-Founder & Partner | 0 | https://shizune.co/investors/profile/alic-chen |
| Deepak Gupta | Co-Founder & Managing Partner | 0 | https://shizune.co/investors/profile/deepak-gupta |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Unnatural Products | Unnatural Products is a startup pairing AI with chemistry to create treatments for drug targets. Its AI-enhanced technology platform creates entirely new drugs by engineering passively permeable, macrocyclic peptides that access traditionally undruggable targets.Unnatural Products was founded in 2017 and is headquartered in Santa Cruz,California. | $6M | Seed | Sep 18, 2019 |  |
| ImpriMed | ImpriMed is a company that creates individualized drug response prediction technology to help veterinarians fight lymphoma. The company's technology provides precision medicine techniques that allow veterinary oncologists to find appropriate anticancer drugs by developing a patient-derived database for pet cancer treatment that can eventuallybe translated into human cancer care, allowing doctors to decide on a final treatment regimen based on a data-driven prediction of response success in each individual patient's body. | $3.7M | Seed | Dec 18, 2018 |  |
| engageLively | Jupyter Hubs as a Service, with built in presentation, visualization, interaction, and a built in point-and-click chart editor | $50K | Convertible Note | Sep 30, 2018 |  |
| DNALite Therapeutics | DNALite Therapeutics, Inc. is an early-stage preclinical biotechnology company committed on bringing the next-generation of drugs to the gastrointestinal tract. Currently for some gastrointestinal diseases, such as colorectal cancer and Crohn's disease, complete or partial removal of the colon and/or rectum is the only treatment Our aimis to prevent not manage the progression of theses diseases. We are doing this by harnessing our proprietary technology to carry DNA to cells that drive these diseases. | $1.5M | Seed | Aug 08, 2018 |  |

4 of 4 investments shown.

## Co-investors
- [Abstract](https://shizune.co/investors/profile/a-list-ventures) — VC Fund, 1 deal together
- [Artis Ventures](https://shizune.co/investors/profile/artis) — VC Fund, 1 deal together
- [Asset Management Ventures (AMV)](https://shizune.co/investors/profile/asset-management-ventures) — VC Fund, 1 deal together
- [Bass Investment](https://shizune.co/investors/profile/bass-investment) — VC Fund, 1 deal together
- [Berkeley Catalyst Fund (BCF)](https://shizune.co/investors/profile/berkeley-catalyst-fund-bcf) — VC Fund, 1 deal together
- [Better Ventures](https://shizune.co/investors/profile/better-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Blue Bear Ventures invest in?

Blue Bear Ventures invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Convertible Note stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Blue Bear Ventures?

Public channels for Blue Bear Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Blue Bear Ventures?

The team at Blue Bear Ventures includes Patrick Scaglia (Managing General Partner and Co-Founder), Alic Chen (Co-Founder & Partner) and Deepak Gupta (Co-Founder & Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co